Literature DB >> 15743688

Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma.

Stephen T Connelly1, Maricris Macabeo-Ong, Nusi Dekker, Richard C K Jordan, Brian L Schmidt.   

Abstract

Inducible nitric oxide synthase (iNOS) is responsible for generating high levels of nitric oxide (NO) in tissues. Increased iNOS expression has been demonstrated in a number of carcinomas including head and neck squamous cell carcinoma (SCC). However, iNOS levels have not been evaluated specifically in oral cavity SCC, or in the precancerous lesions that progress to oral SCC. Also, NO levels have not been measured in oral precancerous or cancerous tissues. We therefore measured iNOS mRNA, iNOS protein and NO in oral SCC, oral dysplasias and normal oral epithelium. We used RT-PCR to quantify and compare iNOS mRNA levels in these oral tissue specimens. We found that iNOS mRNA was overexpressed in 41% of oral SCC but in only 8% of dysplasia specimens (P = 0.003). Immunohistochemistry was used to evaluate iNOS protein levels in oral SCC, oral dysplasias and normal oral epithelium. A significantly higher percentage of oral SCC specimens showed the highest level of iNOS staining relative to the oral dysplasias and normal oral epithelial samples (95% of oral SCC, 50% of dysplasias, and only 0% of normal epithelial controls, P < 0.0001). The positive staining for iNOS was limited to the SCC cells. Production of NO from iNOS was quantified using HPLC and found to be significantly higher in oral SCC (1.45 +/- 0.56 microg/ml) than normal epithelial controls (0.43 +/- 0.26 microg/ml) (P = 0.0013). We conclude that iNOS mRNA levels and NO production are significantly increased, in oral SCC compared to oral dysplasias and normal epithelial controls. These findings suggest that increased iNOS expression and the generation of high NO levels might have a role in oral SCC development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743688     DOI: 10.1016/j.oraloncology.2004.09.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  19 in total

Review 1.  Nitric oxide and cancer therapy: the emperor has NO clothes.

Authors:  Jason R Hickok; Douglas D Thomas
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 2.  Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.

Authors:  Alexis L Santana; Diane Felsen; John A Carucci
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 3.  iNOS expression in oral and gastrointestinal tract mucosa.

Authors:  Nurullah Keklikoglu; Meltem Koray; Humeyra Kocaelli; Sevtap Akinci
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

4.  Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice.

Authors:  Phuong N Quang; Brian L Schmidt
Journal:  J Pain       Date:  2010-01-13       Impact factor: 5.820

5.  Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice.

Authors:  Victoria Pickering; R Jay Gupta; Phuong Quang; Richard C Jordan; Brian L Schmidt
Journal:  Eur J Pain       Date:  2007-07-30       Impact factor: 3.931

6.  The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells.

Authors:  Jennifer E Bradburn; Ping Pei; Laura A Kresty; James C Lang; Allan J Yates; Adam P McCormick; Susan R Mallery
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480

7.  Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions.

Authors:  Susan R Mallery; Jared C Zwick; Ping Pei; Meng Tong; Peter E Larsen; Brian S Shumway; Bo Lu; Henry W Fields; Russell J Mumper; Gary D Stoner
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

8.  Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice.

Authors:  Phuong N Quang; Brian L Schmidt
Journal:  Pain       Date:  2010-03-04       Impact factor: 7.926

9.  Red Mold Rice Mitigates Oral Carcinogenesis in 7,12-Dimethyl-1,2-Benz[a]anthracene-Induced Oral Carcinogenesis in Hamster.

Authors:  Ruei-Lan Tsai; Bing-Ying Ho; Tzu-Ming Pan
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-04       Impact factor: 2.629

10.  Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.

Authors:  Lisa A Ridnour; Kimberly M Barasch; Alisha N Windhausen; Tiffany H Dorsey; Michael M Lizardo; Harris G Yfantis; Dong H Lee; Christopher H Switzer; Robert Y S Cheng; Julie L Heinecke; Ernst Brueggemann; Harry B Hines; Chand Khanna; Sharon A Glynn; Stefan Ambs; David A Wink
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.